Paper Details

  1. Home
  2. Paper Details

Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.

Author: AlaviMehran, HamidiMehrdad

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review provides an overview of the current position of liposome-based drug delivery systems in targeted anticancer chemotherapy. It focuses on the advantages of using liposomes and lipid nanoparticles (LNPs) for delivering chemotherapy drugs to cancer cells, including biocompatibility, controlled release, and reduced toxicity. The review highlights the use of LNPs for targeting breast and prostate cancer.
Paper Details　
Original Abstract of the Article :
Considerable development in the application of injectable drug delivery systems for cancer therapy has occurred in the last few decades. These improvements include liposomes, lipid nanoparticles (LNPs), and other nanoparticles with or without macromolecular conjugates. For example, liposomal doxorub...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/30707682

データ提供：米国国立医学図書館（NLM）

Liposomes and Lipid Nanoparticles: Targeting Cancer with Precision

Cancer treatment is constantly evolving, and drug delivery systems are playing an increasingly important role. This review explores the use of liposomes and lipid nanoparticles (LNPs) as targeted drug delivery systems in cancer therapy. The authors discuss the advantages of these nanocarriers, including their biocompatibility, controlled release properties, and reduced toxicity. The review highlights the potential of these systems for delivering anticancer drugs directly to tumor cells, improving therapeutic efficacy and reducing side effects.

A New Era of Precision Medicine: Targeting Cancer with Nanocarriers

This review highlights the promise of nanocarriers like liposomes and LNPs for improving cancer treatment. These systems offer a more precise approach to delivering anticancer drugs, allowing for targeted delivery to tumor cells while minimizing damage to healthy tissues. This precision delivery approach has the potential to improve therapeutic outcomes and enhance the quality of life for cancer patients.

A New Frontier in Cancer Treatment: Harnessing the Power of Nanocarriers

This review provides a compelling case for the continued development and refinement of nanocarrier-based drug delivery systems for cancer therapy. The potential of these systems for targeted drug delivery offers a new frontier in cancer treatment, holding the promise of more effective and less toxic therapies.

Dr. Camel's Conclusion

Cancer treatment is a challenging journey through a vast desert of uncertainty. Liposomes and lipid nanoparticles are like oases in this desert, offering a precise and targeted approach to delivering cancer therapies. This research underscores the power of nanotechnology in revolutionizing cancer treatment, offering hope for a brighter future for those affected by this devastating disease.
Date :
  1. Date Completed 2019-08-09
  2. Date Revised 2021-02-22
Further Info :

Pubmed ID

30707682

DOI: Digital Object Identifier

dmpt-2018-0032

Related Literature

Article Analysis
・Effects of paclitaxel (with albumin) injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.